SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-17-009541
Filing Date
2017-02-15
Accepted
2017-02-15 10:36:28
Documents
18
Period of Report
2017-02-15
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a17-4543_18k.htm 8-K 18990
2 EX-99.1 a17-4543_1ex99d1.htm EX-99.1 25072
3 GRAPHIC g45431mmi001.gif GRAPHIC 211566
4 GRAPHIC g45431mmi002.gif GRAPHIC 181392
5 GRAPHIC g45431mmi003.gif GRAPHIC 139466
6 GRAPHIC g45431mmi004.gif GRAPHIC 96770
7 GRAPHIC g45431mmi005.gif GRAPHIC 376451
8 GRAPHIC g45431mmi006.gif GRAPHIC 141703
9 GRAPHIC g45431mmi007.gif GRAPHIC 80290
10 GRAPHIC g45431mmi008.gif GRAPHIC 84643
11 GRAPHIC g45431mmi009.gif GRAPHIC 76311
12 GRAPHIC g45431mmi010.gif GRAPHIC 97219
13 GRAPHIC g45431mmi011.gif GRAPHIC 377958
14 GRAPHIC g45431mmi012.gif GRAPHIC 68899
15 GRAPHIC g45431mmi013.gif GRAPHIC 133045
16 GRAPHIC g45431mmi014.gif GRAPHIC 143363
17 GRAPHIC g45431mmi015.gif GRAPHIC 131288
18 GRAPHIC g45431mmi016.gif GRAPHIC 124295
  Complete submission text file 0001104659-17-009541.txt   3441515
Mailing Address 420 LEXINGTON AVENUE SUITE 2012 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE SUITE 2012 NEW YORK NY 10170 212-297-0010
SYNERGY PHARMACEUTICALS, INC. (Filer) CIK: 0001347613 (see all company filings)

IRS No.: 330505269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35268 | Film No.: 17613402
SIC: 2834 Pharmaceutical Preparations